Clinically unsuspected and undetected (clinical stage to) prostate cancer diagnosed on random needle biopsy

Urology

Volumn 53, Issue 3, 1999, Pages 557-560

  Corica, Federico A ^a   Bostwick, David G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; DIAGNOSTIC ACCURACY; HUMAN; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME;

AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 0033106084     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00546-9     Document Type: Article

References (29)

1. Landis S., Murray T., Bolden S., et al. Cancer statistics 1998. CA Cancer J Clin. 48:1998;6-29.
2. Sakr W.A., Grignon D.J., Crissman J.D., et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69 an autopsy study of 249 cases . In Vivo. 8:1994;439-444.
3. Dugan J.A., Bostwick D.G., Myers R.P., et al. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA. 275:1996;288-294.
4. Stamey T.A., Freiha F.S., McNeal J.E., et al. Localized prostate cancer. Cancer. 71:1993;933-938.
5. Schmid H.P., McNeal J.E., Stamey T.A. Observations on the doubling time. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer. 71:1993;2031-2040.
6. Epstein J.I., Walsh P.C., Carmichael M., et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 271:1994;368-374.
7. Ohori M., Wheeler T.M., Dunn J.K., et al. The pathological features and prognosis of prostate cancer detectable with current diagnostic techniques. J Urol. 152:1994;1714-1720.
8. Haas G.P., Sakr W.A. Epidemiology of prostate cancer. CA Cancer J Clin. 47:1997;273-287.
9. Scardino P.T., Weaver R., Hudson M.A. Early detection of prostate cancer. Hum Pathol. 23:1992;211-222.
10. Catalona W.J., Richie J.P., Ahmann F.R., et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer results of a multicenter clinical trial of 6,630 men . J Urol. 151:1994;1283-1290.
11. Mettlin C., Murphy G.P., Babaian R.J., et al. The results of a five-year early prostate cancer detection intervention. Cancer. 77:1996;150-159.
12. Corica A., Marchiotti M., Verga Kuhnke A., et al. Prostatic cancer detection program in Mendoza (abstract). Br J Urol. 80:1997;243.
13. Labrie F., Dupont A., Suburu R., et al. Serum prostate specific antigen as a pre-screening test for prostate cancer. J Urol. 147:1992;846-852.
14. Ellis W.J., Chetner M.P., Preston S.D., et al. Diagnosis of prostatic carcinoma the yield of serum prostate-specific antigen, digital rectal examination and transrectal ultrasonography . J Urol. 152:1994;1520-1525.
15. Flanigan R.C., Catalona W.J., Richie J.P., et al. Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. J Urol. 152:1994;1506-1509.
16. Gann P.H., Hennekens C.H., Stampfer M.J. A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA. 273:1995;289-294.
17. Van Andel G., Vleeming R., Kurth K., et al. Incidental carcinoma of the prostate. Semin Surg Oncol. 11:1995;36-45.
18. Morgentaler A., Bruning C., DeWolf W.C. Occult prostate cancer in men with low serum testosterone levels. JAMA. 276:1996;1904-1906.
19. Catalona W.J., Smith D.S., Ornstein D.K. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. JAMA. 277:1997;1452-1455.
20. Vallancien G., Prapotnich D., Veillon B., et al. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol. 146:1991;1308-1312.
21. Fleshner N.E., O'Sullivan M., Fair W.R. Prevalence and predictors of a positive repeat transrectal ultrasound guided biopsy of the prostate. J Urol. 158:1997;505-508.
22. Bostwick D.G. Neoplasms of the prostate. Bostwick D.G., Eble J.N., Urologic Surgical Pathology. 1997;343-421 Mosby, St Louis.
23. Bostwick D.G. Staging prostate cancer - 1997 current methods and limitations . Eur Urol. 32:1997;2-14.
24. Kabalin J.N., McNeal J.E., Price H.M., et al. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes incidence, histology, and morphometric observations . J Urol. 141:1989;1091-1094.
25. Abbas F., Hockberg D., Civantos F., et al. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol. 30:1996;322-326.
26. McNeal J.E., Kindrachuk R.A., Freiha F.S., et al. Patterns of progression in prostate cancer. Lancet. 1:1986;60-63.
27. Sakr W.A., Hass G.P., Cassin B.F., et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 150:1993;379-385.
28. Guileyardo J.M., Johnson W.D., Welsh R.A., et al. Prevalence of latent prostate cancer on two U.S. populations. J Natl Cancer Inst. 65:1980;311-316.
29. Breslow N., Chan C.W., Dhom G., et al. Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer. 20:1977;680-688.